According to new figures, half of the adults in the US have received at least one jab of the vaccine.
Meanwhile, the Centers for Disease Control and Prevention (CDC) says almost 84 million adults have received two doses.
Almost 130 million people aged 18 and over have received at least one dose of the COVID vaccine. This is around 50.4 per cent of the total adult population.
The Centers for Disease Control and Prevention (CDC) also added almost 84 million adults have two doses of the vaccine. It sums up to around 32.5 per cent of the total adult population.
The US cleared the 50% mark just a day after the reported global death toll from COVID opped 3 million. The tolls were, according to John Hopkins University, though the actual deaths were significantly higher.
The nation’s vaccination rate, at 61.6 doses given per 100 people. However, the rate of doses currently is lagging from Israel. Presently, Israel leads the countries with at least 5 million people at the rate of 119.2 people.
It also trails Chile, the United Arab Emirates, and the UK, which vaccinates at 62 doses per 100 people. These data are from the Our World in Data.
The US states with the highest vaccination rates have a history of voting Democratic and Supporting President Joe Biden. CDC data shows New Hampshire at the top with 71.1 per cent, followed by New Mexico, Connecticut, Massachusetts and Maine.
The demand has not been alike in many regions of Tennessee, mainly the rural.
A poll conducted in March found 36% of Republicans said they’d probably not get vaccinated than the 12% Democrats.
Similarly, a third of rural Americans said they were rolling against getting jabs. Concurrently, fewer than a fourth of people living in cities and suburbs shared that doubt.
More statements on the vaccine
Meanwhile, Dr Anthony Fauci, the nation’s top infectious disease expert, mentioned some vaccine-related statements. He has said that the government is likely to resume the use of Johnson & Johnson’s COVID vaccine this week.
Dr Fauci said he awaits a judgment when advisors to the CDC meet on Friday. The meeting will be to consider the pause in J&J’s single-dose vaccine.
The vaccine was thrown into uncertainty after the Food and Drug Administration and CDC last week. They said they needed more proofs to decide if a handful of rare blood clots were linked to the jab.